Glaucoma

Related records

Broader conditions (6)

• Disease
• Disease by body system or component
• Disorder of orbital region
• Disorder of visual system
• Eye disorder
• Human disease

Narrower conditions (50)

• Acute closed-angle glaucoma
• Anatomical narrow angle borderline glaucoma
• Angle-closure glaucoma
• Anterior segment dysgenesis 3
• Anterior segment dysgenesis 6
• Aqueous misdirection
• Borderline glaucoma
• Chronic closed-angle glaucoma
• Congenital glaucoma
• CYP1B1-related glaucoma with or without anterior segment dysgenesis
• Exfoliation syndrome
• Glaucoma 1, open angle, A
• Glaucoma 1, open angle, J
• Glaucoma 1, open angle, K
• Glaucoma 1, open angle, l
• Glaucoma 1, open angle, M
• Glaucoma 1, open angle, N
• Glaucoma 1, open angle, O
• Glaucoma 1, open angle, P
• Glaucoma 3, primary congenital, C

Trials (1,359)

• "First-in-human" Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers
• "My Eyes, My Light": Amar Chokh, Amar Alo
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
• 12-Month Stability of Diurnal IOP Control on Cosopt
• 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
• 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
• 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy
• 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
• 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination
• 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice
• 24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost
• 24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol
• 24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
• 24-hour IOP-lowering Effect of 0.01% Bimatoprost
• 24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
• 24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)
• 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination
• 24-hr Intraocular Pressure Control With SIMBRINZA ®
• 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
• 5 Years Long Term Results After Standalone CyPass-Implantation

Approved drugs (37)

• Acetazolamide
• Acetazolamide sodium
• Acetylcholine
• Apraclonidine
• Betaxolol
• Bimatoprost
• Brimonidine
• Brimonidine tartrate
• Brinzolamide
• Carbachol
• Carteolol
• Clonidine
• Dapiprazole
• Demecarium
• Dichlorphenamide
• Dipivefrin
• Dorzolamide
• Dorzolamide hydrochloride
• Echothiophate
• Epinephrine

Drugs in development (41)

• Aceclidine Phase 3
• Acetaminophen Early phase 1
• Aflibercept Phase 3
• AMA0076 Phase 2
• Befunolol Phase 2
• Betamethasone Phase 2
• Bevacizumab Phase 3
• Bimatoprost grenod Phase 1
• Bosentan Phase 1
• Cannabinol Phase 2
• Cenegermin Phase 1
• Ciliary neurotrophic factor Phase 2
• Cyclosporine Phase 2
• Decorin Phase 1
• Dexamethasone Phase 3
• Ethacrynic acid Phase 1
• Fluocinolone acetonide Early phase 1
• Fluorouracil Phase 3
• Infliximab Phase 1
• Insulin human Phase 1

Other linked drugs (9)

• Carteolol hydrochloride
• Cholesterol
• Colforsin
• Dexmedetomidine
• Ketorolac
• Prednisolone acetate
• Ripasudil hydrochloride dihydrate
• Rutin
• Triamcinolone